ABSTRACT
Background Catch-up campaigns (CCs) at the introduction of the pneumococcal conjugate vaccines (PCVs) may accelerate the impact of PCVs. However, limited vaccine supplies may delay vaccine introduction if additional doses are needed for such campaigns. We studied the relative impact of introducing PCV13 with and without catch-up campaign, and the implications of potential introduction delays.
Methods We used a dynamic transmission model applied to the population of Nha Trang in Sout central Vietnam. Four strategies were considered: routine vaccination (RV) only, and RV alongside catch-up campaigns among <1y olds (CC1), <2y olds (CC2) and <5y olds (CC5). The model was parameterised with local data on human social contact rates, and was fitted to local carriage data. Post-PCV predictions were based on best estimates of parameters governing post-PCV dynamics, including serotype competition, vaccine efficacy and duration of protection.
Results Our model predicts elimination of vaccine-type (VT) carriage across all age groups within 10 years of introduction in all scenarios with near-complete replacement by non-VT. Most of the benefit of CCs is predicted to occur within the first 3 years after introduction, with the highest impact in the first year, when IPD incidence is predicted to be 11% (95%CrI 9 – 14%) lower than RV with CC1, 25% (21 – 30 %) lower with CC2 and 38% (32 – 46%) lower with CC5.
However, CCs would only prevent more cases of IPD insofar such campaigns do not delay introduction by more than 31 (95%CrI 30 – 32) weeks with CC1, 58 (53 – 63) weeks with CC2 and 89 (78 – 101) weeks for CC5.
Conclusion CCs are predicted to offer a substantial additional reduction in pneumococcal disease burden over RV alone, if their implementation does not result in much introduction delay. Those findings are important to help guide vaccine introduction in countries that have not yet introduced PCV, particularly in Asia.
LIST OF ABBREVIATIONS
- CC
- Catch-up campaign
- CC1
- CC in <1 year olds
- CC2
- CC in <2 year olds
- CC5
- CC in <5 year olds
- IPD
- Invasive Pneumococcal Disease
- MCMC
- Markov Chain Monte-Carlo
- NVT
- Non vaccine type
- PCV
- pneumococcal conjugate vaccine
- PCV7
- seven-valent PCV
- PCV10
- 10-valent PCV
- PCV13
- 13-valent PCV
- RV
- Routine vaccination
- vaccine efficacy against carriage conferring full protection
- vaccine efficacy against carriage conferring partial protection
- VT
- Vaccine Type